🕵️ Verona Pharma PLC ($VRNA)
SEC insider & ownership activity, last 12 months · CIK 1657312 · every row links its SEC filing
Over the last 12 months insiders sold $7.1M with no open-market buying against it. Mark W. Hahn sold $2.7M through a 10b5-1 trading plan in 1 lots (Aug). One red-flag 8-K in the window: Delisting notice (3.01), Oct 7, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 13 sellers, $7.1M (13 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Mark W. Hahn | 0 | – | 1 | $2.7M | Aug 1, 2025 |
| David Zaccardelli | 0 | – | 1 | $2.7M | Aug 1, 2025 |
| Kathleen Rickard | 0 | – | 1 | $767K | Aug 1, 2025 |
| Austwick Michael | 0 | – | 1 | $148K | Aug 1, 2025 |
| Cunningham Kenneth | 0 | – | 1 | $142K | Aug 1, 2025 |
| Edwards Martin | 0 | – | 1 | $142K | Aug 1, 2025 |
| Andrew Fisher | 0 | – | 1 | $126K | Aug 1, 2025 |
| Deschamps Lisa | 0 | – | 1 | $124K | Aug 1, 2025 |
| Sinha Vikas | 0 | – | 1 | $57K | Aug 1, 2025 |
| Shah Mahendra | 0 | – | 1 | $47K | Aug 1, 2025 |
| David R. Ebsworth | 0 | – | 1 | $25K | Aug 1, 2025 |
| Christina Ackermann | 0 | – | 1 | $24K | Aug 1, 2025 |
| Brady James Aloysius | 0 | – | 1 | $11K | Aug 1, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock Portfolio Management LLC | 6.0% | 13G | Oct 17, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Acquisition or disposition (2.01) | Oct 7, 2025 | filing ↗ |
| Delisting notice (3.01) | Oct 7, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Oct 7, 2025 | filing ↗ |
| Change of control (5.01) | Oct 7, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 7, 2025 | filing ↗ |
| Shareholder vote (5.07) | Sep 24, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 24, 2025 | filing ↗ |
| Other events (8.01) | Sep 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 24, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 5, 2025 | filing ↗ |